Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Finished

MeTIC Methyltransferase inhibitors for treatment of COVID19

Coordinator
Technische Universitaet Muenchen, Germany
Runs
1 June 2022 to 30 November 2023
Status
Finished
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101069369

What the project is doing

In the project's own words, from its summary on CORDIS.

Our IP secured drug DZNep is effective in treating SARS-CoV-2 infections in preclinical disease models and uniquely suppresses virus growth, triggers the innate immunity and facilitates tissue regeneration. The ERC-PoC will enable the transition from preclinical to clinical research.

Topics

Who is involved

OrganisationCityCountryRole
Technische Universitaet MuenchenMuenchenGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI